within Pharmacolibrary.Drugs.ATC.N;

model N06BX06_1
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 4.333333333333334e-06,
    adminDuration  = 600,
    adminMass      = 1000 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.00114,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.00106,
    k12             = 0.088,
    k21             = 0.088
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>N06BX06_1</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Citicoline (CDP-choline) is an endogenous nucleotide involved in the biosynthesis of phosphatidylcholine, a component of cell membranes. It is used as a neuroprotective agent in the management of stroke, traumatic brain injury, and cognitive impairment. It is available as a supplement/medication in some countries, but its clinical efficacy remains debated and it is not FDA approved in the United States.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adults following intravenous bolus injection.</p><h4>References</h4><ol><li><p>Secades, JJ, &amp; Lorenzo, JL (2006). Citicoline: pharmacological and clinical review, 2006 update. <i>Methods and findings in experimental and clinical pharmacology</i> 28 Suppl B 1–56. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/17171187/\">https://pubmed.ncbi.nlm.nih.gov/17171187</a></p></li><li><p>Gareri, P, et al., &amp; Bruni, AC (2015). The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives. <i>Clinical interventions in aging</i> 10 1421–1429. DOI:<a href=\"https://doi.org/10.2147/CIA.S87886\">10.2147/CIA.S87886</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/26366063/\">https://pubmed.ncbi.nlm.nih.gov/26366063</a></p></li><li><p>Secades, JJ, &amp; Frontera, G (1995). CDP-choline: pharmacological and clinical review. <i>Methods and findings in experimental and clinical pharmacology</i> 17 Suppl B 1–54. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/8709678/\">https://pubmed.ncbi.nlm.nih.gov/8709678</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end N06BX06_1;
